HCA
VKTX icon

Harbor Capital Advisors’s Viking Therapeutics VKTX Stock Holding History

Harbor Capital Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$846K Buy
26,009
+9,240
+55% +$297K 0.07% 357
2025
Q4 		$590K Buy
16,769
+600
+4% +$21.3K 0.05% 436
2025
Q3 		$425K Sell
16,169
-87,377
-84% -$2.61M 0.03% 522
2025
Q2 		$2.74M Sell
103,546
-11,643
-10% -$306K 0.12% 238
2025
Q1 		$2.78M Sell
115,189
-14,094
-11% -$445K 0.13% 231
2024
Q4 		$5.2M Sell
129,283
-9,969
-7% -$568K 0.23% 139
2024
Q3 		$8.82M Buy
139,252
+75,820
+120% +$4.45M 0.38% 70
2024
Q2 		$3.36M Buy
63,432
+55,068
+658% +$3.61M 0.26% 103
2024
Q1 		$686K Buy
+8,364
New +$372K 0.09% 302

Other funds holding VKTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return